Related Experiment Videos
ALS surrogate markers. MUNE.
1Columbia College of Physicians and Surgeons, Columbia Presbyterian Medical Center, New York, NY 10032, USA. clg33@columbia.edu
Summary
Motor unit number estimation (MUNE) quantifies motor unit loss in amyotrophic lateral sclerosis, aiding therapy assessment and tracking disease progression. MUNE is a valuable tool for motor neuron disease research.
Area of Science:
- Neuroscience
- Neurology
Background:
- Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor unit loss.
- Motor unit number estimation (MUNE) is increasingly utilized in ALS research.
Purpose of the Study:
- To highlight the utility of MUNE in quantifying motor unit loss in ALS.
- To discuss MUNE's role in assessing therapeutic interventions and tracking disease progression.
- To emphasize MUNE's potential as an early biomarker in clinical trials.
Main Methods:
- MUNE methods enable quantitative assessment of motor unit numbers.
- MUNE can simultaneously evaluate collateral reinnervation.
- Application in animal models and human patients.
Main Results:
- Studies show an average 50% motor unit loss every six months in ALS progression.
- MUNE provides insights into motor unit behavior during anterior horn cell degeneration.
- MUNE incorporation into clinical trials shows promising results as a biomarker.
Conclusions:
- MUNE is an effective tool for studying motor neuron diseases like ALS.
- Refined MUNE methods are crucial for advancing motor neuron disease research.
- MUNE aids in evaluating neuroprotective and reinnervation-enhancing therapies.